Integra Lifesciences Holdings Corp

IARTNASDAQ · USD
13.25USD0.00 (-2.22%)
777

Integra Lifesciences Holdings Corp (IART) Covered Calls

Integra Lifesciences Holdings Corp trades in the Medical Devices industry with an IV Rank of 2.38%, low versus the past year. IART's highest covered call setup is the $17.50 strike expiring Mar 19, 2027, sorted by theoretical annualized return. It's 25.18% out of the money with 123 days to expiration, a 25.89% return until expiration, and a 76.84% theoretical annualized return. Across the setups shown, annualized returns run from 24.15% to 76.84% at strikes between $15.00 and $17.50, with 123 to 213 days to expiration, as of Nov 16, 2026.

Read more

Running IART covered calls helps you generate income from Integra Lifesciences Holdings Corp shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best IART covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If IART stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling IART covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given IART covered call is worth writing.

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services.

2027-03-1912317.5025.180.101.60362.0025.8976.84-0.72+0.331431.50
2027-06-1721317.5025.180.203.60372.0026.6145.60-1.43+0.45163.40
2027-03-1912315.007.300.403.90142.0010.1630.14-2.86+0.54993.50
2027-06-1721315.007.300.954.70197.0014.0924.15-6.80+0.5863.75

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV Rank2.38% Low
  • Market cap (M$)1,031
  • 52 weeks high-35.33%
  • 52 weeks low52.30%
  • Analyst recommendationHold
    2.75
  • Target price$15.67
    18.26% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-10-21
  • P/E80.55
  • Future P/E5.59
  • EPS (ttm)0.16
  • EPS growth next 5 years3.47%

As of Nov 20, 2026